指南与共识

美国风湿病学会成人风湿病患者COVID-19大流行期间管理指南(第3版)

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3.
指南 / 共识 · Arthritis Rheumatol · 2020-12-05

该指南由北美10名风湿病学家和4名感染病专家组成的工作组制定,采用改良Delphi流程对临床问题形成推荐声明。最终声明旨在促进COVID-19大流行期间成人风湿病患者的优化诊疗,但因证据水平低且文献快速演变,指南以「活文件」形式发布并预期更新。

要点

  • 工作组由10名风湿病学家和4名感染病专家组成,采用改良Delphi流程形成推荐。
  • 共识强度基于投票离散度分为低、中、高,批准需中位数达到预设 agreement 水平。
  • 指南定位为「活文件」,因现有证据水平低且文献快速演变,预期未来更新。

核心结论

  • 该指南为COVID-19大流行期间成人风湿病患者的管理提供推荐声明,以促进优化诊疗。

研究设计与样本

  • 工作组包括来自北美的10名风湿病学家和4名感染病专家,采用改良Delphi流程(异步匿名邮件投票和网络研讨会)对推荐声明进行投票。
  • 投票采用1-9分数值评分系统,中位数7-9、4-6、1-3分别定义为同意、不确定、不同意,共识强度根据投票离散度分为低、中、高。

主要发现

  • 经工作组批准的推荐声明合并形成最终指南。

关键数值与推荐

  • 批准需中位数投票达到预设 agreement 水平(7-9为同意,4-6为不确定,1-3为不同意),且共识强度为中等或高。

临床怎么用

  • 临床医生可参考该指南在COVID-19大流行期间管理成人风湿病患者,但需注意证据水平低且指南将随文献更新。

局限性

  • 现有证据水平低,且文献快速演变,指南以「活文件」形式呈现,未来预期更新。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID-19) pandemic. METHODS: A task force, including 10 rheumatologists and 4 infectious disease specialists from North America, was convened. Clinical questions were collated, and an evidence report was rapidly generated and disseminated. Questions and drafted statements were reviewed and assessed using a modified Delphi process. This included asynchronous anonymous voting by email and webinars with the entire panel. Task force members voted on agreement with draft statements using a 1-9-point numerical scoring system, and consensus was determined to be low, moderate, or high based on the dispersion of votes. For approval, median votes were required to meet predefined levels of agreement (median values of 7-9, 4-6, and 1-3 defined as agreement, uncertainty, or disagreement, respectively) with either moderate or high levels of consensus. RESULTS: Draft guidance statements approved by the task force have been combined to form final guidance. CONCLUSION: These guidance statements are provided to promote optimal care during the current pandemic. However, given the low level of available evidence and the rapidly evolving literature, this guidance is presented as a "living document," and future updates are anticipated.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Mikuls TR, Johnson SR, Fraenkel L, et al. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3. Arthritis Rheumatol. 2020. PMID: 33277981. doi:10.1002/art.41596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。